Clinical trial
A Study in People With Mild Hypertension
NCT00374855 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00374855 |
|---|---|
| Title | A Study in People With Mild Hypertension |
| Official title | Protocol H8D-MC-EMBH PPAR Alpha (LY518674): a Phase 2 Dose-Response Study to Evaluate the Blood Pressure-Lowering Effect in Essential Hypertension |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Mild Hypertension |
| Intervention type | Drug |
| Interventions | PPAR alpha, Hydrochlorothiazide, Placebo |
| Enrollment | 153 |
| Start date | Sep 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Sep 12, 2006 |
| Last update posted | May 15, 2007 |
| Countries | Sweden |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: